GFM
ORKA

GF Fund Management’s Oruka Therapeutics ORKA Stock Holding History

GF Fund Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.3K Buy
1,087
+137
+14% +$4.76K ﹤0.01% 391
2025
Q4 		$28.8K Buy
950
+144
+18% +$4.01K ﹤0.01% 467
2025
Q3 		$15.5K Sell
806
-90
-10% -$1.33K ﹤0.01% 521
2025
Q2 		$10K Hold
896
– – ﹤0.01% 569
2025
Q1 		$9.19K Buy
896
+161
+22% +$2.01K ﹤0.01% 576
2024
Q4 		$14.3K Buy
+735
New +$17.9K ﹤0.01% 504

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

GF Fund Management's ORKA Position: Q1 2026 in Review

GF Fund Management increased its Oruka Therapeutics (ORKA) stake by 14% in Q1 2026, buying an estimated $4.76K and bringing the position to 1,087 shares worth $53.3K. The position accounts for ﹤0.01% of the portfolio, ranked #391.

GF Fund Management first reported a position in ORKA in Q4 2024 and has held it in 6 quarters since. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • GF Fund Management held 1,087 shares of Oruka Therapeutics worth $53.3K as of Q1 2026.
  • GF Fund Management bought 137 Oruka Therapeutics shares in Q1 2026, an estimated $4.76K.
  • Oruka Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #391 holding.
  • GF Fund Management first reported a position in Oruka Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.